{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:36:24Z","timestamp":1789821384994,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejphar.2006.01.032","type":"journal-article","created":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T07:09:30Z","timestamp":1141715370000},"page":"271-279","source":"Crossref","is-referenced-by-count":25,"title":["Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats"],"prefix":"10.1016","volume":"534","author":[{"given":"Philip","family":"Janiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bidouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cadrouvele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gouraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Grataloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bruneval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Eric O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.01.032_bib1","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2337\/diacare.26.8.2421","article-title":"ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1","volume":"26","author":"Amann","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2006.01.032_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1523-1755.2000.00214.x","article-title":"Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy","volume":"58","author":"Banda","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/CEH-120017739","article-title":"Increased renal angiotensin II AT1 receptor function in obese Zucker rats","volume":"25","author":"Becker","year":"2003","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ejphar.2006.01.032_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.RES.83.9.952","article-title":"Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells","volume":"83","author":"Chen","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2006.01.032_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ddr.430320208","article-title":"Developmental aspect of the adipose tissue rennin\u2013angiotensin system: therapeutic implications","volume":"32","author":"Crandall","year":"1994","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2006.01.032_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1681\/ASN.V641295","article-title":"The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats","volume":"6","author":"Crary","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005344-200109000-00008","article-title":"The angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression and macrophage accumulation in apoE-deficient mice","volume":"38","author":"Dol","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1523-1755.2000.00814.x","article-title":"Studies of renal injury: III. Lipid-induced nephropathy in type II diabetes","volume":"57","author":"Dominguez","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1046\/j.1523-1755.1999.00731.x","article-title":"Brief periods of hyperphagia cause renal injury in the obese Zucker rat","volume":"56","author":"Gades","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","article-title":"Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats","volume":"38","author":"Henriksen","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2006.01.032_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ajcn\/66.4.890","article-title":"Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia","volume":"66","author":"Johnson","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2006.01.032_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/en.138.4.1512","article-title":"Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells","volume":"138","author":"Jones","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2006.01.032_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ki.1988.51","article-title":"Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats","volume":"33","author":"Kasiske","year":"1988","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1523-1755.1999.00643.x","article-title":"Renin\u2013angiotensin blockade lowers MCP-1 expression in diabetic rats","volume":"56","author":"Kato","year":"1999","journal-title":"Kidney Int."},{"issue":"Suppl. 77","key":"10.1016\/j.ejphar.2006.01.032_bib15","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1046\/j.1523-1755.2000.07715.x","article-title":"Role of angiotensin II in diabetic nephropathy","volume":"58","author":"Leehey","year":"2000","journal-title":"Kidney Int."},{"issue":"345","key":"10.1016\/j.ejphar.2006.01.032_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"20","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2006.01.032_bib17","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2006.01.032_bib18","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1210\/en.142.12.5220","article-title":"Angiotensinogen-deficient mice exhibit impairment of diet-induced weigh gain with alteration in adipose tissue development and increased locomotor activity","volume":"142","author":"Massiera","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2006.01.032_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diabetes.41.6.736","article-title":"Prospective study of microalbuminuria as predictor of mortality in NIDDM","volume":"41","author":"Mattock","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2006.01.032_bib20","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1046\/j.1523-1755.2000.00418.x","article-title":"Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion","volume":"58","author":"McCarty","year":"2000","journal-title":"Kidney Int."},{"issue":"Suppl. 86","key":"10.1016\/j.ejphar.2006.01.032_bib21","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1046\/j.1523-1755.64.s86.12.x","article-title":"Renin\u2013angiotensin system activation and interstitial inflammation in human diabetic nephropathy","volume":"64","author":"Mezzano","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/JDI-120021156","article-title":"Increased urinary excretion of monocyte chemoattractant protein 1 in proteinuric renal diseases","volume":"25","author":"Morii","year":"2003","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejphar.2006.01.032_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1681\/ASN.2004080649","article-title":"Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats","volume":"16","author":"Nagai","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib24","first-page":"H2701","article-title":"Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression","volume":"272","author":"Nickenig","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib25","first-page":"S218","article-title":"Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitus","volume":"63","author":"O'Donnell","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1523-1755.2002.00107.x","article-title":"Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats","volume":"61","author":"Okada","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/ajkd.1998.v31.pm9428473","article-title":"Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephritic rats","volume":"31","author":"Park","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2006.01.032_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2006.01.032_bib29","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1046\/j.1523-1755.62.s82.3.x","article-title":"Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy","volume":"62","author":"Rincon-Choles","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4049\/jimmunol.161.1.430","article-title":"Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis","volume":"161","author":"Ruiz-Ortega","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib31","first-page":"64","article-title":"Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats : protective effects of ACE inhibition","volume":"73","author":"Sassy-Prigent","year":"1995","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2006.01.032_bib32","first-page":"F496","article-title":"Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effect of enalapril","volume":"263","author":"Schmitz","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2006.01.032_bib33","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type I receptor blockers induce peroxisome proliferator-activated receptor-g activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2006.01.032_bib34","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/diabetes.48.10.2066","article-title":"Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation","volume":"48","author":"Singh","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2006.01.032_bib35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib36","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1523-1755.2004.00661.x","article-title":"ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats","volume":"65","author":"Toblli","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00004872-199506000-00015","article-title":"Early and late hemodynamic and morphological effects of AT1 receptor blockade during genetic hypertension development","volume":"13","author":"Vacher","year":"1995","journal-title":"J. Hypertension"},{"key":"10.1016\/j.ejphar.2006.01.032_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ki.1994.290","article-title":"Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats","volume":"46","author":"Veniant","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib39","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.1523-1755.2000.00311.x","article-title":"Up-regulation of monocyte chemoattractant protein-1 in tubulo-interstitial lesions of human diabetic nephropathy","volume":"58","author":"Wada","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2006.01.032_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0272-6386(97)90023-8","article-title":"The role of angiotensin II in diabetic nephropathy: emphasis on non-hemodynamic mechanisms","volume":"29","author":"Wolf","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2006.01.032_bib41","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1523-1755.2002.00332.x","article-title":"Effect of combining ACE inhibitor and statin in severe experimental nephropathy","volume":"61","author":"Zoja","year":"2002","journal-title":"Kidney Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:47:11Z","timestamp":1683380831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0014299906000306"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.01.032","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1157748.618969","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}